[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  Lycanbull [@Lycanbull](/creator/twitter/Lycanbull) on x 4957 followers Created: 2025-05-28 12:31:21 UTC $HALO Halozyme Announces Bristol Myers Squibb Received European Commission Approval for Subcutaneous Opdivo® (nivolumab) Co-Formulated with ENHANZE® Across Multiple Solid Tumor Indications  XXX engagements  **Related Topics** [$halo](/topic/$halo) [$bmy](/topic/$bmy) [stocks healthcare](/topic/stocks-healthcare) [Post Link](https://x.com/Lycanbull/status/1927704246041854008)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Lycanbull @Lycanbull on x 4957 followers
Created: 2025-05-28 12:31:21 UTC
$HALO Halozyme Announces Bristol Myers Squibb Received European Commission Approval for Subcutaneous Opdivo® (nivolumab) Co-Formulated with ENHANZE® Across Multiple Solid Tumor Indications
XXX engagements
Related Topics $halo $bmy stocks healthcare
/post/tweet::1927704246041854008